Treatment outcomes with sorafenib in advanced hepatocellular carcinoma: A single-center retrospective study

被引：0
|
作者：
Prejac, J. [1 ]
Tomek, D. [1 ]
Kekez, D. [1 ]
Majerovic, M. [2 ]
Plestina, S. [1 ]
机构：
[1] Univ Hosp Ctr Zagreb, Dept Oncol, Zagreb, Croatia
[2] Univ Hosp Ctr Zagreb, Dept Internal Med, Zagreb, Croatia
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.05.339
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-285
引用
收藏
页码：S194 / S194
页数：1
相关论文
共 50 条
  • [21] Individualized therapy of advanced hepatocellular carcinoma by TACE and/or sorafenib: retrospective analysis using single center data
    Glaser, D.
    Bartolomaeus, A.
    Lux, C.
    Krammer-Steiner, B.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 262 - 262
  • [22] Sorafenib for Egyptian patients with advanced hepatocellular carcinoma; single center experience
    Abdel-Rahman, Omar
    Abdelwahab, Manal
    Shaker, Mohammed
    Abdelwahab, Sherif
    Elbassiony, Mohammed
    Ellithy, Mahmoud
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2014, 26 (01) : 9 - 13
  • [23] Comparison of the short-term outcomes of open and laparoscopic hepatectomy in the treatment of recurrent hepatocellular carcinoma: a single-center retrospective study
    Wang, Ke
    Sun, Jian-Nan
    Wu, Sheng-Dong
    Lu, Cai-De
    Hu, Yang-Ke
    Ma, Yi-Jie
    TRANSLATIONAL CANCER RESEARCH, 2022, : 4373 - 4380
  • [24] Sorafenib with TACE improves the survival of hepatocellular carcinoma patients with more than 10 cm tumor: a single-center retrospective study
    Aktas, Gokmen
    Kus, Tulay
    Kalender, Mehmet Emin
    Kervancioglu, Selim
    Sevinc, Alper
    Kul, Seval
    Camci, Celaletdin
    JOURNAL OF BUON, 2017, 22 (01): : 150 - 156
  • [25] Sorafenib for the treatment of advanced hepatocellular carcinoma
    Connock, M.
    Round, J.
    Bayliss, S.
    Tubeuf, S.
    Greenheld, W.
    Moore, D.
    HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 : 17 - 21
  • [26] Retrospective Evaluation of Patients with Hepatocellular Carcinoma: Single-Center Experience
    Temel, Tuncer
    Bilge, Ugur
    Ozakyol, Aysegul Harmanci
    KONURALP TIP DERGISI, 2015, 7 (01): : 57 - 60
  • [27] EFFICACY AND SAFETY OF SORAFENIB AND CRYOTHERAPY FOR ADVANCED HEPATOCELLULAR CARCINOMA (HCC): A SINGLE CENTER RANDOMIZED STUDY
    Yang, Yongping
    Lu, Yinying
    Wang, Chunping
    Qu, Jianhui
    Chang, Xiujuan
    An, Linjing
    Hu, Ke-Qin
    HEPATOLOGY, 2011, 54 : 1367A - 1367A
  • [28] Clinical features and surgical outcomes of fibrolamellar hepatocellular carcinoma: retrospective analysis of a single-center experience
    Anastasia Lemekhova
    Daniel Hornuss
    Georgios Polychronidis
    Philipp Mayer
    Christian Rupp
    Thomas Longerich
    Karl-Heinz Weiss
    Markus Büchler
    Arianeb Mehrabi
    Katrin Hoffmann
    World Journal of Surgical Oncology, 18
  • [29] Clinical features and surgical outcomes of fibrolamellar hepatocellular carcinoma: retrospective analysis of a single-center experience
    Lemekhova, Anastasia
    Hornuss, Daniel
    Polychronidis, Georgios
    Mayer, Philipp
    Rupp, Christian
    Longerich, Thomas
    Weiss, Karl-Heinz
    Buechler, Markus
    Mehrabi, Arianeb
    Hoffmann, Katrin
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2020, 18 (01)
  • [30] Sorafenib in Advanced Hepatocellular Carcinoma: A Nationwide Retrospective Study of Efficacy and Tolerability
    Kostner, Anne Helene
    Sorensen, Morten
    Olesen, Rene Krojgaard
    Gronbaek, Henning
    Lassen, Ulrik
    Ladekarl, Morten
    SCIENTIFIC WORLD JOURNAL, 2013,
12345